Evidence map›Paper›PMID 34617432›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2022

Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Özlem Satırer, İnci Cevher Zeytin, Berna Alkan, Jale Karakaya, Duygu Çetinkaya, Fatma Visal Okur

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Özlem SatırerHacettepe University Faculty of Medicine, Department of Pediatrics, Ankara, Turkey
İnci Cevher ZeytinHacettepe University, Center for Stem Cell Research and Development (PEDI-STEM), Ankara, TurkeyORCID 0000-0002-7689-5889
Berna AlkanHacettepe University, Center for Stem Cell Research and Development (PEDI-STEM), Ankara, TurkeyORCID 0000-0003-3715-2756
Jale KarakayaHacettepe University Faculty of Medicine, Department of Biostatistics, Ankara, TurkeyORCID 0000-0002-7222-7875
Duygu ÇetinkayaHacettepe University, Center for Stem Cell Research and Development (PEDI-STEM), Ankara, TurkeyORCID 0000- 0003-3593-6493
Fatma Visal OkurHacettepe University, Center for Stem Cell Research and Development (PEDI-STEM), Ankara, TurkeyORCID 0000-0002-1679-6205
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Angiogenic factors (AFs) released under endothelial stress are reflective of tissue healing, while some may also contribute to tissue damage/inflammation. We investigated whether alterations in the pre-transplant levels of AFs were associated with the risk of acute graft-versus-host disease (aGvHD). Materials and Methods: The pre-conditioning plasma levels of angiopoietin-2 (Ang2), endoglin, and follistatin were measured for 37 patients together with inflammatory markers. The index values defined were evaluated to better identify the alterations. Results: The patients had higher pre-conditioning levels of Ang2, endoglin, and follistatin compared to controls. The patients with aGvHD had higher Ang2 index and lower albumin index scores in comparison to those without aGvHD. Multivariate analysis revealed that the pre-transplant Ang2 index was an independent risk factor for aGvHD development. Conclusion: Pre-transplant evaluation of plasma Ang2 levels along with inflammatory status even before conditioning is associated with endothelial vulnerability. The pre-transplant Ang2 index could be a promising candidate to estimate the risk of aGvHD.

Indexed as

Angiopoietin-2Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAcute DiseaseHumansPreoperative PeriodRiskAngiopoietin-2AngiogenesisAngiopoietin-2Graft-versus-host diseaseHematopoietic stem cell transplantationInflammation

Identifiers

PMID34617432
PMCPMC8886278
OpenAlexW3204484190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.